D. Clark

发表

Dose-Response of Inhaled Drugs in Asthma

B. Lipworth, D. Clark, 1997, Clinical pharmacokinetics.

Lung delivery of salbutamol by dry powder inhaler (Turbuhaler) and small volume antistatic metal spacer (Airomir CFC-free MDI plus NebuChamber).

B. Lipworth, D. Clark, D. Clark, 1997, The European respiratory journal.

Climate Change and Conceptual Change

D. Clark, 2013 .

Pharmacokinetics, Safety, and Tolerability After Single and Multiple Oral Doses of Varenicline in Elderly Smokers

T. Fullerton, A. Burstein, H. Faessel, 2006, Journal of clinical pharmacology.

Single‐Dose Pharmacokinetics of Varenicline, a Selective Nicotinic Receptor Partial Agonist, in Healthy Smokers and Nonsmokers

A. Burstein, M. Gibbs, H. Faessel, 2006, Journal of clinical pharmacology.

Lack of a pharmacokinetic interaction between a new smoking cessation therapy, varenicline, and digoxin in adult smokers

A. Burstein, M. Troutman, S. Willavize, 2008, European Journal of Clinical Pharmacology.

Effects of airway calibre on lung delivery of nebulised salbutamol.

B. Lipworth, D. Clark, 1997, Thorax.

Pharmacokinetics and extrapulmonary beta 2 adrenoceptor activity of nebulised racemic salbutamol and its R and S isomers in healthy volunteers.

B. Lipworth, C. Arbeeny, D. Clark, 1997, Thorax.

Comparative adrenal suppression with inhaled budesonide and fluticasone propionate in adult asthmatic patients.

B. Lipworth, D. Clark, A. Grove, 1996, Thorax.

Adrenal suppression with inhaled budesonide and fluticasone propionate given by large volume spacer to asthmatic children.

B. Lipworth, R. Clark, D. Clark, 1996, Thorax.

Adrenal suppression with chronic dosing of fluticasone propionate compared with budesonide in adult asthmatic patients.

B. Lipworth, D. Clark, 1997, Thorax.

Warfarin Pharmacodynamics Unaffected by Cilomilast

J. Kelly, R. Murdoch, D. Webber, 2001, The Annals of pharmacotherapy.

Adrenocortical activity with repeated administration of one-daily inhaled fluticasone propionate and budesonide in asthmatic adults

B. Lipworth, A. Wilson, M. Devlin, 1998, European Journal of Clinical Pharmacology.

Adrenocortical activity with repeated twice daily dosing of fluticasone propionate and budesonide given via a large volume spacer to asthmatic school children.

B. Lipworth, L. McFarlane, D. Clark, 1997, Thorax.

Lung delivery of salbutamol given by breath activated pressurized aerosol and dry powder inhaler devices.

B. Lipworth, D. Clark, 1997, Pulmonary pharmacology & therapeutics.

Effect of multiple actuations, delayed inhalation and antistatic treatment on the lung bioavailability of salbutamol via a spacer device.

B. Lipworth, D. Clark, 1996, Thorax.

Lung bioavailability of chlorofluorocarbon free, dry powder and chlorofluorocarbon containing formulations of salbutamol.

B. Lipworth, D. Clark, 1996, British journal of clinical pharmacology.

Evaluation of corticotropin releasing factor stimulation and basal markers of hypothalamic-pituitary-adrenal axis suppression in asthmatic patients.

B. Lipworth, D. Clark, 1997, Chest.

Lung delivery of non-CFC salbutamol via small volume metal spacer and large volume plastic spacer devices compared with an open vent jet nebulizer.

B. Lipworth, D. Clark, 1998, British journal of clinical pharmacology.

Lack of Pharmacokinetic and Pharmacodynamic Interactions Between a Smoking Cessation Therapy, Varenicline, and Warfarin: An In Vivo and In Vitro Study 1

R. Walsky, R. Obach, A. Burstein, 2007, Journal of clinical pharmacology.

Adrenal suppression with high doses of inhaled fluticasone propionate and triamcinolone acetonide in healthy volunteers

B. Lipworth, A. Wilson, L. McFarlane, 1997, European Journal of Clinical Pharmacology.

Endocrine deficit after fractionated total body irradiation.

A. Ogilvy-Stuart, S. Shalet, R. Stevens, 1992, Archives of disease in childhood.

An Overview of the Pharmacokinetics of Cilomilast (Ariflo®), a New, Orally Active Phosphodiesterase 4 Inhibitor, in Healthy Young and Elderly Volunteers

J. Upward, A. Port, P. Wyld, 2001, Journal of clinical pharmacology.

Bioavailability of the Oral Selective Phosphodiesterase 4 Inhibitor Cilomilast

J. Kelly, R. Murdoch, B. Zussman, 2001, Pharmacotherapy.

PHARMACOKINETICS AND DISPOSITION

B. Lipworth, D. Clark, 1997 .

Meperidine Exerts Agonist Activity at the (cid:1) 2B -Adrenoceptor Subtype

M. Davies, M. Maze, P. Tonner, 2002 .

Meperidine Exerts Agonist Activity at the &agr;2B-Adrenoceptor Subtype

M. Davies, M. Maze, P. Tonner, 2002, Anesthesiology.

Familial antithrombin III deficiency and Mycoplasma pneumoniae pneumonia.

F. Preston, D. Clark, M. D. Creagh, 1991, Journal of Clinical Pathology.

Impact of Magnesium on Oxytocin Receptor Function

B. Zou, Vimala N. Bharadwaj, M. Klukinov, 2022, Pharmaceutics.

Cilomilast: pharmacokinetic and pharmacodynamic interactions with digoxin.

C. Schubert, J. Kelly, R. Murdoch, 2001, Clinical therapeutics.

Multiple‐Dose Pharmacokinetics of the Selective Nicotinic Receptor Partial Agonist, Varenicline, in Healthy Smokers

M. Stolar, A. Burstein, M. Gibbs, 2006, Journal of clinical pharmacology.

Decreased body-core temperature during acute hypoxemia in guinea pigs during postnatal maturation: a regulated thermoregulatory response.

J. Fewell, D. Clark, 1996, Canadian journal of physiology and pharmacology.

Evaluating UV Absorbers and Antioxidants for Topical Treatment of Upholstery Fabrics

P. C. Crews, D. Clark, 1990 .

Evaluating UV Absorbers

P. C. Crews, D. Clark, 1990 .

Early lung absorption profile of non-CFC salbutamol via small and large volume plastic spacer devices.

B. Lipworth, D. Clark, 1998, British journal of clinical pharmacology.